Navigation Links
Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
Date:4/8/2011

PARSIPPANY, N.J., April 8, 2011 /PRNewswire/ -- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX), an emerging specialty pharmaceutical company, today announced James Scibetta, chief financial officer, is scheduled to present at the BioCentury Future Leaders in the Biotech Industry Conference on Friday, April 15, 2011, at 11:30 a.m. EDT being held at the Millennium Broadway Hotel & Conference Center in New York City. Mr. Scibetta is expected to present an overview of the company.

A live audio webcast of Pacira's presentation can be accessed by visiting the investors section of the company's website at investor.pacira.com. A replay of the webcast will be archived on the Pacira website for two weeks following the presentation date.

About Pacira

Pacira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development, manufacture and commercialization of novel pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. In December 2010, Pacira announced that its New Drug Application (NDA) for EXPAREL, the company's most advanced investigational product candidate, had been accepted for filing by the U.S. Food and Drug Administration (FDA). The FDA has assigned a Prescription Drug User Fee Act (PDUFA) goal date of July 28, 2011 for the review of the EXPAREL NDA. EXPAREL is a bupivacaine-based product and has completed extensive Phase 3 clinical development for postoperative analgesia by infiltration. EXPAREL consists of bupivacaine encapsulated in DepoFoam, which is designed to address the limitations of widely used medications by enhancing their dosing and/or administration profile. Additional information about Pacira is available at

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results
2. Pacira Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
3. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
4. Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
5. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
6. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
7. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
8. Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment
9. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA)
10. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
11. Idenix Pharmaceuticals Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/16/2015)... Kenneth C. Frazier , chairman and chief executive officer ... the Board of the Pharmaceutical Research and Manufacturers of America ... John J. Castellani announced that he will be retiring ... to PhRMA Board Frazier formerly held the position ... and CEO of Pfizer, Inc. Also elected were George ...
(Date:4/16/2015)... April 16, 2015  Rosewind Corporation (OTCMKTS: RSWN) ... merger with a newly formed specialty healthcare company ... on addressing urological disorders. The merged company, which ... has commenced operations and incorporates the pipeline assets ... Company,s strategy is to build a late-stage and ...
(Date:4/16/2015)... , Apr. 16, 2015 Research and Markets ... addition of the "Cancer Growth Inhibitors Market ... their offering. Cancer growth inhibitors market ... difficult to demarcate different categories. For instance, a ... a large molecule because they have same inhibitory ...
Breaking Medicine Technology:Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 2Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 3Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 4Merck Chairman and CEO Kenneth C. Frazier Becomes PhRMA Board Chairman 5Rosewind Corporation Shifts Focus to Develop Late-Stage Therapeutics for Urological and Related Conditions 2Rosewind Corporation Shifts Focus to Develop Late-Stage Therapeutics for Urological and Related Conditions 3Global Cancer Growth Inhibitors Market & Clinical Pipeline Analysis 2015 2Global Cancer Growth Inhibitors Market & Clinical Pipeline Analysis 2015 3
... Va., Aug. 30, 2011 Dilon expands its ... alliance with PenRad, rated #1 Mammography Information System ... innovation, high quality and customer loyalty are the ... provide leading-edge breast imaging tools, and an information ...
... announced the results of its Comprehensive Client Performance ... a 19 percent increase in their total revenue ... go-live. SuccessEHS believes this increase in revenue directly ... conjunction with the implementation of SuccessEHS software and ...
Cached Medicine Technology:Dilon Diagnostics® Partners With PenRad® 2Dilon Diagnostics® Partners With PenRad® 3SuccessEHS Solution Leads to 19 Percent Increase in Revenue 2SuccessEHS Solution Leads to 19 Percent Increase in Revenue 3
(Date:4/18/2015)... 2015 On April 14th, 2015, Symantec released ... which they say, “exposes a tactical shift by cyberattackers.” With ... were introduced in 2014 - almost a million a day ... to be identified and patched by prominent manufacturers – as ... doing business in a digital world can be fraught with ...
(Date:4/18/2015)... FL (PRWEB) April 18, 2015 PHOENIX, ... Hillsborough County, along with 11 other secure destruction professionals ... Secure Destruction Specialists (CSDS). He will now display “CSDS” ... exams were offered before the National Association of Information ... Illinois and another Grapevine, Texas. Of the 20 people ...
(Date:4/17/2015)... 2015 John Evans, a Gardant affordable ... Patio from 2 p.m. to 3 p.m. on April ... Executive Ct. in Pekin, Illinois, serves older adults of ... help to maintain their independence. , Becky Baker will ... will be served during the luau. , For more ...
(Date:4/17/2015)... Newport Beach, California (PRWEB) April 17, 2015 ... plastic surgeon Dr. Kevin Sadati of the ... one of Orange County’s top beauty experts. The ... and neck lift, facial stem cell fat grafting, eyelid ... approach to facial plastic surgery has resulted ...
(Date:4/17/2015)... have seen healing, a lot of healing, and a lot ... Kafader of Friendship Village. “People have found purpose. ... have created beautiful pieces of art.” For the past eight ... was launched to benefit residents of the retirement community. , ... Institute in Chicago, worked as an intern at Friendship Village, ...
Breaking Medicine News(10 mins):Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 2Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 3Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 4Health News:Cyber Attackers Continue to Fine Tune Deception and Stealth Tactics According to New Report 5Health News:John Evans Supportive Living Community Prepares for Party on the Patio 2Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 2Health News:Orange County Facial Plastic Surgeon Featured in Premier Magazine Focused on Beauty 3Health News:Healing At Friendship Village Due To Art Therapy 2
... ON (January 28) Diagnosing a nasty cough is ... developed at McMaster University, which has just been approved ... in the United States. , This new test simultaneously ... the common cold, helping doctors more accurately diagnose patients. ...
... biologically younger than couch potato set, British study ... People who are physically active in their free ... a new British study suggests. , "A sedentary ... premature death. Inactivity may diminish life expectancy not ...
... guiding the biopsy of suspicious breast cancer lesions is ... of the smallest ones detected by standard imaging systems, ... initial testing of the PEM/PET system, designed and constructed ... National Accelerator Facility, West Virginia University School of Medicine ...
... Morphines serious side effect as a pain killer its ... in research with mice by genetically modifying a single trait ... drug can be developed to similarly block dependency. , ... and appears in the journals January 23 print edition. The ...
... Forgetful Casanovas are lucky in love. , At least ... of new research on the mating habits and nervous ... which examined both the voles behavior and their brains, ... the National Academy of Sciences. , Prairie voles, aka ...
... unknown, researchers say , , MONDAY, Jan. 28 (HealthDay News) ... was associated with the development of chronic bronchitis, but ... "The mechanisms underlying the association between snoring and chronic ... the Jan. 28 issue of Archives of Internal ...
Cached Medicine News:Health News:McMaster test detects the most prevalent respiratory viruses 2Health News:Sedentary Lifestyle Accelerates Aging 2Health News:Device zeroes in on small breast tumors 2Health News:Morphine dependency blocked by single genetic change 2Health News:Zoologists: Lusty voles, mindless of danger, mate like rabbits 2Health News:Zoologists: Lusty voles, mindless of danger, mate like rabbits 3Health News:Study Links Snoring to Chronic Bronchitis 2
... Ultra MD Super Pulse sealed CO2 ... versatility backed by the experience and support ... years of surgical laser experience. All settings ... finger. The Ultra MD Super Pulse surgical ...
The compact size and portability of the Epic system makes it a cost-effective solution for single or multi-office use....
A soft contact lens that lets presbyopes see clearly and comfortably at all distances , without the hassles of bifocals or reading glasses. Recommended for daily wear. Also approved for extended wear...
... display of corneal layers: endothelium, ... epithelial layers. Accurate analysis of ... keratocytes, nerve fibres, basal & ... surgery and pathology: optical pachymetry, ...
Medicine Products: